Terms: = Lymphoma AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
26 results:
1. Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type.
Xu T; Li Y; Liu Y; Ning B; Wu H; Wei Y
Ann Hematol; 2023 Dec; 102(12):3521-3532. PubMed ID: 37702822
[TBL] [Abstract] [Full Text] [Related]
2. Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.
Xing P; Zhao Q; Zhang L; Wang H; Huang D; Hu P; Sun Y; Shi Y
BMC Med; 2022 Nov; 20(1):453. PubMed ID: 36424628
[TBL] [Abstract] [Full Text] [Related]
3. Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma.
Oluwole OO; Chen JMH; Chan K; Patel AR; Jansen JP; Keeping S; Zheng Y; Snider JT; Locke FL
Leuk Lymphoma; 2022 Dec; 63(13):3052-3062. PubMed ID: 36048026
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
6. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
[TBL] [Abstract] [Full Text] [Related]
7. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
Front Immunol; 2020; 11():602482. PubMed ID: 33488600
[TBL] [Abstract] [Full Text] [Related]
8. Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients.
Gallais F; Oberic L; Faguer S; Tavitian S; Lafont T; Marsili S; Brice A; Chatelut E; Puisset F
Ther Drug Monit; 2021 Jun; 43(3):408-415. PubMed ID: 32925658
[TBL] [Abstract] [Full Text] [Related]
9. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.
Mok T; Camidge DR; Gadgeel SM; Rosell R; Dziadziuszko R; Kim DW; Pérol M; Ou SI; Ahn JS; Shaw AT; Bordogna W; Smoljanović V; Hilton M; Ruf T; Noé J; Peters S
Ann Oncol; 2020 Aug; 31(8):1056-1064. PubMed ID: 32418886
[TBL] [Abstract] [Full Text] [Related]
10. Criteria-Based Imaging and Response Evaluation of lymphoma 20 Years After Cheson: What is New?
Skusa C; Weber MA; Böttcher S; Thierfelder KM
Rofo; 2020 Jul; 192(7):657-668. PubMed ID: 32215902
[TBL] [Abstract] [Full Text] [Related]
11. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Stellbrink HJ; Arribas JR; Stephens JL; Albrecht H; Sax PE; Maggiolo F; Creticos C; Martorell CT; Wei X; Acosta R; Collins SE; Brainard D; Martin H
Lancet HIV; 2019 Jun; 6(6):e364-e372. PubMed ID: 31068272
[TBL] [Abstract] [Full Text] [Related]
12. A U.S. Cost Analysis of Triplet Regimens for Patients with Previously Treated Multiple Myeloma.
Hollmann S; Moldaver D; Goyert N; Grima D; Maiese EM
J Manag Care Spec Pharm; 2019 Apr; 25(4):449-459. PubMed ID: 30917078
[TBL] [Abstract] [Full Text] [Related]
13. A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Trnĕný M; Verhoef G; Dyer MJ; Ben Yehuda D; Patti C; Canales M; Lopez A; Awan FT; Montgomery PG; Janikova A; Barbui AM; Sulek K; Terol MJ; Radford J; Guidetti A; Di Nicola M; Siraudin L; Hatteville L; Schwab S; Oprea C; Gianni AM
Haematologica; 2018 Aug; 103(8):1351-1358. PubMed ID: 29748443
[TBL] [Abstract] [Full Text] [Related]
14. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.
Hoppe BS; Hill-Kayser CE; Tseng YD; Flampouri S; Elmongy HM; Cahlon O; Mendenhall NP; Maity A; McGee LA; Plastaras JP
Ann Oncol; 2017 Sep; 28(9):2179-2184. PubMed ID: 28911093
[TBL] [Abstract] [Full Text] [Related]
15. Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.
Rathe M; Sorensen GL; Wehner PS; Holmskov U; Sangild PT; Schmiegelow K; Müller K; Husby S
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667327
[TBL] [Abstract] [Full Text] [Related]
16. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Yang JJ; Landier W; Yang W; Liu C; Hageman L; Cheng C; Pei D; Chen Y; Crews KR; Kornegay N; Wong FL; Evans WE; Pui CH; Bhatia S; Relling MV
J Clin Oncol; 2015 Apr; 33(11):1235-42. PubMed ID: 25624441
[TBL] [Abstract] [Full Text] [Related]
17. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database.
Guru Murthy GS; Venkitachalam R; Mehta P
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963
[TBL] [Abstract] [Full Text] [Related]
18. Photon-beam radiotherapy in pregnant patients: can the fetal dose be limited to 10 cGy or less?
Kourinou KM; Mazonakis M; Lyraraki E; Damilakis J
Phys Med; 2015 Feb; 31(1):85-91. PubMed ID: 25455441
[TBL] [Abstract] [Full Text] [Related]
19. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
Olszewski AJ; Ali S
Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
[TBL] [Abstract] [Full Text] [Related]
20. [Maternal and perinatal outcomes in pregnant women with leukemia].
Nomura RM; Igai AM; Faciroli NC; Aguiar IN; Zugaib M
Rev Bras Ginecol Obstet; 2011 Aug; 33(8):174-81. PubMed ID: 22159617
[TBL] [Abstract] [Full Text] [Related]
[Next]